A Study Comparing the Effectiveness and Safety of Teriflunomide and Interferon Beta-1a in Patients With Relapsing Multiple Sclerosis

NCT00883337 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

324

Enrollment

INDUSTRY

Sponsor class

Conditions

Multiple Sclerosis

Interventions

DRUG: Interferon β-1a
DRUG: Teriflunomide

Sponsor

Sanofi